Central obesity as a potential causal risk factor for atrial fibrillation: evidence from Mendelian randomization study-Reference-Cited by-同舟云学术

Central obesity as a potential causal risk factor for atrial fibrillation: evidence from Mendelian randomization study

Published:2024-03-01 Issue:3 Volume:26 Page:
ISSN:1099-5129
Container-title:Europace
language:en
Short-container-title:

Author:

Deng Yingjian¹,Li Linlin¹,Li Qiang¹^ORCID,Guo Jincun¹,Cai Binni¹,Zhou Faguang¹^ORCID,Chang Dong¹^ORCID

Affiliation:

1. Department of Cardiology, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University , 2999 Jinshan Road, Xiamen, Fujian Province 361000, PR China

Funder

Scientific and Technological Innovation

Fujian Province

Science and Technology Plan Projects of Fujian Province

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/europace/advance-article-pdf/doi/10.1093/europace/euae061/56888653/euae061.pdf

Reference11 articles.

1. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study;Larsson;Eur Heart J,2020

2. Association of obesity with incident atrial fibrillation in Korea and the United Kingdom;Choi;Sci Rep,2023

3. Obesity and coronary heart disease: epidemiology, pathology, and coronary artery imaging;Katta;Curr Probl Cardiol,2021

4. Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies;Aune;Eur J Epidemiol,2017

5. Risk factor profile for newly diagnosed atrial fibrillation: 4-year follow-up of annual health examinations in a Japanese adult cohort;Nagata;J Arrhythm,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon‐like peptide‐1 receptor agonist semaglutide reduces atrial fibrillation incidence: A systematic review and meta‐analysis;European Journal of Clinical Investigation;2024-07-26